Abstract
Treatment ofHER2/neu-overexpressing target cells with interferon γ(IFNγ) (200–2000 U/ml for 3 days) markedly enhances their sensitivity to lymphokine-activated killer (LAK) cell lysis. Increased sensitivity is associated with an up-regulation of intercellular adhesion molecule ICAM-1 determinants and a down-regulation ofHER2/neu expression. In the present study, we show that exposure to another cytokine, tumor necrosis factor α (200 U/ml for 3 days), also decreasedHER2/neu expression but had no effect on LAK cell lysis and ICAM-1 expression. This suggests that down-regulation of oncogene expression is not sufficient by itself to induce an enhanced sensitivity to LAK cell lysis. IFN-induced enhanced lysis was associated with an increased binding between effectors and targets, and antibodies to ICAM-1 as well as its counter-receptor LFA-1, blocked the increased binding and lysis. Treatment with IFNγ still significantly enhanced lysis even when concanavalin A was added to the assay to induce maximal binding, indicating that a post-binding effect also participated in enhanced cytotoxicity. These post-binding alterations, were also sensitive to blocking with anti-ICAM-1 and anti-LFA-1 antibodies. Treatment with IFN also sensitized targets to lysis by T cells in the presence of lectin but had no effect on the relative resistance of HER2+ cells to lysis mediated by perforin or TNF. Together these data demonstrate the importance of ICAM-1 determinants in binding and post-binding events in the IFN-induced increased lysis ofHER2/neu + targets.
Similar content being viewed by others
References
Bernasconi S, Peri G, Sironi M, Mantovani A (1991) Involvement of leukocyte (β2) integrins (CD18/CD11) in human monocyte tumoricidal activity. Int J Cancer 49: 267
Blanchard DK, Hall RE, Djeu JY (1990) Role of CD18 in lymphokine activated killer (LAK) cell-mediated lysis of human monocytes: comparison with other LAK targets. Int J Cancer 45: 312
De Fries RU, Golub SH (1988) Characteristics and mechanism of IFN-γ induced protection of human tumor cells from lysis by lymphokine-activated killer cells. J Immunol 140: 3686
Fady C, Gardner AM, Gera JF, Lichtenstein A (1992) Interferon-induced increase in sensitivity of ovarian cancer targets to lysis by lymphokine-activated killer cells: selective effects on HER2/neu-over-expressing cells. Cancer Res 52: 764
Fady C, Gardner AM, Gera JF, Lichtenstein A (1993) Resistance ofHER2/neu-overexpressing tumor targets to lymphokine activated killer cell mediated lysis: evidence for deficiency of binding and post-binding events. Cancer Immunol Immunother 36: 307
Groenberg A, Ferm MT, Reynolds CW, Ortaldo JR (1988) IFN-γ treatment of K562 cells inhibits natural killer triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes. J Immunol 140: 4397
Guarini L, Temponi M, Bruce JN, Pollon AP, Duigou GJ, Moulton TA, Ferrone S, Fisher PB (1990) Expression and modulation by cytokines of the intercellular adhesion molecule-1 (ICAM-1) in human central nervous system tumor cell cultures. Int J Cancer 46: 1041
Henkart PA (1985) Mechanism of lymphocyte-mediated cytotoxicity. Annu Rev Innumol 3: 31
Laatikainen A, Schultz-Suhonen L, Mantyjarvi (1991) Effect of interferon on the sensitivity of bovine-papilloma-virus-transformed cell lines to cell mediated cytotoxicity. Cancer Immunol Immunother 35: 205
Lagadec P, Saraya KA, Balkwill FR (1991) Human small cell lung cancer cells are cytokine-resistant but NK/LAK sensitive. Int J Cancer 48: 311
Lichtenstein A, Berenson J, Gera J, Waldburger K, Martinez-Maza O, Berek JS (1990) Resistance of human ovarian cancer cells to tumor necrosis factor and lymphokine-activated killer cells: correlation with expression ofHER2/neu oncogene. Cancer Res 50: 7364
Lichtenstein A, Gera J, Berenson J, Ware CF (1991) Inhibitors of poly ADP-ribose polymerase decrease the resistance ofHER2/neu-expressing cancer cells to the cytotoxic effects of tumor necrosis factor. J Immunol 146: 2052
Lichtenstein A, Fady C, Gera JF, Gardner A, Chazin V, Kelley D, Berenson J (1992) Effects of beta 2 microglobulin antisense oligonucleotides on sensitivity ofHER2/neu oncogene-expresing and non-expressing target cells to lymphocyte-mediated lysis. Cell Immunol 141: 219
Mortarini R, Belli F, Parmiani G, Anachini A (1990) Cytokine-mediated modulation of HLA-class II, ICAM-1. LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL-1-β, rTNF-α, rIFN-γ, rIL4, and their combinations. Int J Cancer 45: 334
Moy VT, Brian AA (1992) Signaling by lymphocyte function-associated antigen 1 (LFA-1) in B cells: enhanced antigen presentation after stimulation through LFA-1. J Exp Med 175: 1
Naganuma H, Kiessling R, Patarroyo M, Hansson M, Handgretinger R, Gronberg A (1991) Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine activated killer cells: participation of ICAM-1 induction on target cells. Int J Cancer 47: 527
Phillips JH, Lanier LL (1986) Lectin dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen. J Immunol 136: 1579
Podack ER (1985) Molecular mechanism of lymphocyte-mediated tumor lysis. Immunol Today 6: 21
Ramirez R, Solana R, Carracedo J, Alonso MC, Pena J (1992) Mechanisms involved in NK resistance induced by IFN-γ. Cellular Immunol 140: 248
Shimizu Y, Van Seventer GA, Horgan FJ, Shaw S (1990) Regulated expression and binding of 3 VLAβ(β1) integrin receptors on T cells. Nature 345: 250
Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Goeddel DV (1991). The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88: 9292
Timonen T, Ortaldo JR, Herberman R (1981) Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 153: 569
Van Kooyk Y, Van de Wiel-Van Kemerade P, Weder P, Kuijpers TW, Fidgor CG (1989) Enhancement of LFA-1 mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes. Nature 342: 811
Van Seventer GA, Shimizu Y, Horgan KJ, Shaw S (1990) The LFA-1 ligand ICAM-1 provides an important co-stimulatory signal for T cell receptor-mediated activation of resting cells. J Immunol 144: 4579
Yarden A, Kimchi A (1986) Tumor necrosis factor reduces c-myc expression and cooperates with interferon γ in Hela cells. Science 234: 1419
Young JDE, Hengartner H, Podack ER, Cohn ZA (1986) Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell 44: 849
Author information
Authors and Affiliations
Additional information
Supported by research funds of the Veteran's Administration, the California Institute for Cancer Research and Jonsson Cancer Center core grant CA 16042 funded by NIH
Rights and permissions
About this article
Cite this article
Fady, C., Gardner, A., Gera, J.F. et al. Interferon-γ-induced increased sensitivity ofHER2/neu-overexpressing tumor cells to lymphokine-activated killer cell lysis: importance of ICAM-1 in binding and post-binding events. Cancer Immunol Immunother 37, 329–336 (1993). https://doi.org/10.1007/BF01518456
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01518456